Pub. Date : 2020 Sep
PMID : 33006584
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | PARP inhibitors are also approved as maintenance treatment following a response to platinum-based therapy in the recurrent setting, irrespective of biomarker status. | Platinum | poly(ADP-ribose) polymerase 1 | Homo sapiens |
| 2 | Additionally, PARP inhibitors are approved as third-line treatment and beyond in lieu of chemotherapy for patients with BRCA-associated cancers, and as fourth-line treatment and beyond for patients with platinum-sensitive homologous recombination-deficient tumors. | Platinum | poly(ADP-ribose) polymerase 1 | Homo sapiens |